Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I.
Year: 1989
Type: article
Source: PubMed
Authors: M N Pollak, C Polychronakos, H Guyda
Institution: McGill University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W134041648
